Transcat (TRNS) Earnings Date & Reports

Key Takeaways

• Transcat reported second quarter fiscal 2027 revenue of $97.1 million, up 18% year over year and above analyst consensus estimates.
• Adjusted earnings per share (EPS) came in at $0.64, well ahead of consensus, reflecting strong profit flow-through.
• Service organic revenue growth accelerated to 16%, marking the company's 70th consecutive quarter of service revenue growth.
• Service gross margin expanded 220 basis points (bps) to 34.4%, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 23% to $14.9 million.
• Management raised its full-year fiscal 2027 service organic revenue growth outlook to low double digits, up from high single digits.
• For more detail on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for additional insights.
• Explore Trending AI Robots to see how AI-driven trading strategies are navigating the current market environment.

Earnings Context and Why It Matters

Transcat, Inc. is a leading provider of accredited calibration services and a value-added distributor of test and measurement equipment. Its results for the second quarter of fiscal 2027, ended September 26, 2026, offer a key read on demand across highly regulated end markets such as life sciences, aerospace and defense, and energy. Because a large share of the company's revenue comes from recurring calibration services, the quarter also provides valuable insight into pricing power, margin trends, and customer retention. Investors closely watch service organic growth and gross margin expansion as leading indicators of the company's ability to compound profitability while continuing to pursue strategic acquisitions.

Reported Results

Transcat delivered consolidated revenue of $97.1 million for the second quarter of fiscal 2027, an 18% increase from the prior year. Service revenue grew 23% to $64.8 million, including 16% organic growth, while distribution revenue rose 10% to $32.3 million. The results exceeded Wall Street's consensus revenue estimate of roughly $92 million.

Consolidated gross profit increased 22% to $32.6 million, with gross margin expanding 110 bps to 33.6%. Service gross margin widened 220 bps to 34.4%. Net income grew 90% year over year, and diluted EPS rose 79% to $0.25. Adjusted diluted EPS of $0.64 was up 46% and comfortably ahead of consensus, while adjusted EBITDA increased 23% to $14.9 million with a margin of 15.4%.

On guidance, management raised its fiscal 2027 full-year service organic revenue growth outlook to the low double digits, up from a prior outlook of high single digits, and reiterated expectations for continued service gross margin expansion.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Transcat, it offers a practical way to surface comparable setups and emerging opportunities across the calibration and measurement equipment sector.

Market Reaction and Investor Sentiment

Transcat shares moved higher following the release, with early reports indicating the stock rose around 6% in response to the earnings beat and raised guidance. Investor sentiment was supported by the combination of accelerating organic service growth, meaningful margin expansion, and the company's decision to lift its full-year outlook. The 70th consecutive quarter of service revenue growth reinforced confidence in the durability of Transcat's recurring revenue model. The broad-based nature of the growth, spanning geographies and end markets, further encouraged investors that the momentum is not dependent on a single segment or customer.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will focus on whether Transcat can sustain its double-digit service organic growth while continuing to expand margins. Management expects service gross margin expansion of at least 100 bps year over year in the second half of fiscal 2027, driven by Lean operating principles, business mix optimization, and pricing.

Acquisition activity remains a central pillar of the strategy. The August acquisition of Southeastern Biomedical Associates extended the company's biomedical calibration presence into hospital networks across the southeastern United States, and management has signaled that strategic M&A (mergers and acquisitions) will remain a priority. Investors will also watch the higher-margin rental business, which continues to support distribution segment growth.

Key factors to monitor include the pace of new large customer wins, the integration of recent acquisitions, and any changes in demand across regulated end markets. The company also pointed to early but tangible productivity benefits from AI initiatives, which could become a more meaningful margin driver over time. While the results were strong, investors should continue to track leverage, operating free cash flow, and the trajectory of distribution margins as additional measures of execution.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations